Explore
Validate
Learn
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA004899 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA004899, RRID:AB_1078273
- Product name
- Anti-BCL6
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human BCL6, Gene description: B-cell CLL/lymphoma 6, Alternative Gene Names: BCL5, BCL6A, LAZ3, ZBTB27, ZNF51, Validated applications: IHC, ICC, Uniprot ID: P41182, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references BCL6-SPECC1L: A Novel Fusion Gene in Nasopharyngeal Carcinoma
Topography of transcriptionally active chromatin in glioblastoma
Inducible knock-out of BCL6 in lymphoma cells results in tumor stasis
Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
Molecular Analysis of Precursor Lesions in Familial Pancreatic Cancer
Fang S, Xia T, Fu J, Li T, Zhong Q, Han F
Technology in Cancer Research & Treatment 2022;21
Technology in Cancer Research & Treatment 2022;21
Topography of transcriptionally active chromatin in glioblastoma
Xu L, Chen Y, Huang Y, Sandanaraj E, Yu J, Lin R, Dakle P, Ke X, Chong Y, Koh L, Mayakonda A, Nacro K, Hill J, Huang M, Gery S, Lim S, Huang Z, Xu Y, Chen J, Bai L, Wang S, Wakimoto H, Yeo T, Ang B, Müschen M, Tang C, Tan T, Koeffler H
Science Advances 2021;7(18)
Science Advances 2021;7(18)
Inducible knock-out of BCL6 in lymphoma cells results in tumor stasis
Schlager S, Salomon C, Olt S, Albrecht C, Ebert A, Bergner O, Wachter J, Trapani F, Gerlach D, Voss T, Traunbauer A, Jude J, Hinterndorfer M, Minnich M, Schweifer N, Blake S, Zinzalla V, Drobits B, McConnell D, Kraut N, Pearson M, Zuber J, Koegl M
Oncotarget 2020;11(9):875-890
Oncotarget 2020;11(9):875-890
Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
Wehrhan F, Gross C, Creutzburg K, Amann K, Ries J, Kesting M, Geppert C, Weber M
Journal of Translational Medicine 2019;17(1)
Journal of Translational Medicine 2019;17(1)
Molecular Analysis of Precursor Lesions in Familial Pancreatic Cancer
Algül H, Crnogorac-Jurcevic T, Chelala C, Barry S, Harada T, Bhakta V, Lattimore S, Jurcevic S, Bronner M, Lemoine N, Brentnall T
PLoS ONE 2013;8(1):e54830
PLoS ONE 2013;8(1):e54830
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent staining of human cell line U-251 MG shows localization to nucleoplasm.
- Sample type
- Human
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human tonsil and pancreas tissues using HPA004899 antibody. Corresponding BCL6 RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
